Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA
- PMID: 8432869
- PMCID: PMC288010
- DOI: 10.1172/JCI116249
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA
Abstract
The lack of HLA class I antigen expression by the melanoma cell line SK-MEL-33 is caused by a unique lesion in beta 2-microglobulin (beta 2-mu). Sequencing of beta 2-mu mRNA detected a guanosine deletion at position 323 in codon 76 that causes a frameshift with a subsequent introduction of a stop codon at a position 54 base upstream of the normal position of the stop codon in the message. The loss of 18 amino acids and the change of 6 amino acids, including a cysteine at position 80 in the carboxy terminus of beta 2-mu, are likely to cause marked changes in the structure of the polypeptide. The latter may account for the inability of beta 2-mu to associate with HLA class I heavy chains and for its lack of reactivity with the anti-beta 2-mu mAb tested. HLA class I antigen expression on SK-MEL-33 cells was reconstituted after transfection with a wild-type B2m gene, therefore indicating that the abnormality of endogenous B2m gene is the only mechanism underlying lack of HLA class I antigen expression by SK-MEL-33 cells. The guanosine deletion in B2m gene was detected also in the melanoma tissue from which SK-MEL-33 cells had originated. Therefore, the molecular lesion identified in the SK-MEL-33 melanoma cell line is not caused by a mutation acquired during growth in vitro but is likely to reflect a somatic mutation during tumor progression.
Similar articles
-
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.Cancer Immunol Immunother. 2012 Sep;61(9):1359-71. doi: 10.1007/s00262-012-1321-6. Epub 2012 Jul 26. Cancer Immunol Immunother. 2012. PMID: 22833104 Free PMC article. Review.
-
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.J Clin Invest. 1991 Jan;87(1):284-92. doi: 10.1172/JCI114984. J Clin Invest. 1991. PMID: 1898655 Free PMC article.
-
Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.Cancer Res. 1993 Sep 15;53(18):4303-9. Cancer Res. 1993. PMID: 7689931
-
Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.Cancer Res. 1998 May 15;58(10):2149-57. Cancer Res. 1998. PMID: 9605759
-
Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.Melanoma Res. 1997 Aug;7 Suppl 2:S67-74. Melanoma Res. 1997. PMID: 9578419 Review.
Cited by
-
The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association.Biochem J. 2002 Nov 1;367(Pt 3):703-14. doi: 10.1042/BJ20020200. Biochem J. 2002. PMID: 12162790 Free PMC article.
-
HLA associations in the antitumor response against malignant melanoma.J Immunother Emphasis Tumor Immunol. 1995 Nov;18(4):242-52. doi: 10.1097/00002371-199511000-00005. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8680652 Free PMC article.
-
Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma.Cancer Gene Ther. 2012 Dec;19(12):811-7. doi: 10.1038/cgt.2012.69. Epub 2012 Oct 5. Cancer Gene Ther. 2012. PMID: 23037806 Free PMC article. Review.
-
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.Cancer Immunol Immunother. 2012 Sep;61(9):1359-71. doi: 10.1007/s00262-012-1321-6. Epub 2012 Jul 26. Cancer Immunol Immunother. 2012. PMID: 22833104 Free PMC article. Review.
-
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.Cancer Sci. 2007 Nov;98(11):1795-802. doi: 10.1111/j.1349-7006.2007.00586.x. Epub 2007 Aug 28. Cancer Sci. 2007. PMID: 17725806 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
